Latest Insider Transactions at International Flavors & Fragrances Inc (IFF)
This section provides a real-time view of insider transactions for International Flavors & Fragrances Inc (IFF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERNATIONAL FLAVORS & FRAGRANCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERNATIONAL FLAVORS & FRAGRANCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 05
2021
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,635
-6.34%
|
$227,265
$139.0 P/Share
|
|
Apr 05
2021
|
Andreas Fibig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,407
-10.81%
|
$1,307,573
$139.0 P/Share
|
|
Apr 05
2021
|
Nicolas Mirzayantz President, Nourish |
SELL
Payment of exercise price or tax liability
|
Direct |
1,600
-4.28%
|
$222,400
$139.0 P/Share
|
|
Apr 02
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,569
+13.97%
|
-
|
|
Apr 02
2021
|
Robert G. Anderson Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+9.77%
|
-
|
|
Apr 02
2021
|
Francisco Fortanet EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,282
+14.24%
|
-
|
|
Apr 02
2021
|
Andreas Fibig CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,413
+19.75%
|
-
|
|
Apr 02
2021
|
Nicolas Mirzayantz President, Nourish |
BUY
Exercise of conversion of derivative security
|
Direct |
4,710
+11.18%
|
-
|
|
Mar 15
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83
-1.4%
|
$11,288
$136.79 P/Share
|
|
Mar 15
2021
|
Gonzalez Susana Suarez EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181
+2.95%
|
-
|
|
Mar 15
2021
|
Robert G. Anderson Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
40
-0.28%
|
$5,440
$136.79 P/Share
|
|
Mar 15
2021
|
Robert G. Anderson Controller |
BUY
Grant, award, or other acquisition
|
Direct |
120
+0.84%
|
-
|
|
Mar 15
2021
|
Francisco Fortanet EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.34%
|
$10,064
$136.79 P/Share
|
|
Mar 15
2021
|
Francisco Fortanet EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
193
+0.89%
|
-
|
|
Mar 15
2021
|
Nicolas Mirzayantz President, Nourish |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.4%
|
$18,088
$136.79 P/Share
|
|
Mar 15
2021
|
Nicolas Mirzayantz President, Nourish |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.17%
|
-
|
|
Feb 19
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-18.3%
|
$26,410
$139.24 P/Share
|
|
Feb 19
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
616
+37.24%
|
-
|
|
Feb 19
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-28.82%
|
$38,503
$139.24 P/Share
|
|
Feb 19
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
708
+42.42%
|
-
|
|
Feb 19
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-21.74%
|
$26,688
$139.24 P/Share
|
|
Feb 19
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
584
+39.81%
|
-
|
|
Feb 15
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
24
-8.66%
|
$3,264
$136.21 P/Share
|
|
Feb 15
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
58
+17.31%
|
-
|
|
Feb 15
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
27
-8.28%
|
$3,672
$136.21 P/Share
|
|
Feb 15
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
81
+19.9%
|
-
|
|
Feb 15
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-7.66%
|
$4,760
$136.21 P/Share
|
|
Feb 15
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
105
+18.68%
|
-
|
|
Feb 14
2021
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-40.0%
|
$19,856
$136.21 P/Share
|
|
Feb 14
2021
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+50.0%
|
-
|
|
Feb 14
2021
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-32.88%
|
$16,320
$136.21 P/Share
|
|
Feb 14
2021
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+50.0%
|
-
|
|
Feb 14
2021
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-32.95%
|
$23,528
$136.21 P/Share
|
|
Feb 14
2021
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
525
+50.0%
|
-
|
|
Feb 10
2021
|
Michael L Ducker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,668
+50.0%
|
-
|
|
Jan 08
2021
|
Anne Chwat EVP, GC, & Corp. Sec'y |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.39%
|
$18,083
$107.99 P/Share
|
|
Jan 08
2021
|
Anne Chwat EVP, GC, & Corp. Sec'y |
BUY
Exercise of conversion of derivative security
|
Direct |
469
+1.07%
|
-
|
|
Jan 02
2021
|
Rustom Jilla CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
996
-21.92%
|
$104,580
$105.08 P/Share
|
|
Jan 02
2021
|
Rustom Jilla CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,945
+39.32%
|
-
|
|
Dec 31
2020
|
Matthias Haeni Divisional CEO, Taste |
SELL
Payment of exercise price or tax liability
|
Direct |
1,684
-3.74%
|
$181,872
$108.84 P/Share
|
|
Dec 31
2020
|
Matthias Haeni Divisional CEO, Taste |
BUY
Exercise of conversion of derivative security
|
Direct |
5,090
+10.16%
|
-
|
|
Nov 02
2020
|
Richard O'Leary EVP & Integration Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,660
-12.2%
|
$384,300
$105.07 P/Share
|
|
Nov 02
2020
|
Richard O'Leary EVP & Integration Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+19.95%
|
-
|
|
Mar 30
2020
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,492
+0.01%
|
$1,053,612
$111.5 P/Share
|
|
Mar 27
2020
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
53,806
+0.06%
|
$5,972,466
$111.46 P/Share
|
|
Mar 26
2020
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,036
+0.02%
|
$5,453,924
$109.82 P/Share
|
|
Mar 25
2020
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
103,548
+0.03%
|
$10,561,896
$102.61 P/Share
|
|
Mar 24
2020
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,159
+0.05%
|
$9,196,218
$102.34 P/Share
|
|
Mar 23
2020
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
134,267
+0.05%
|
$13,023,899
$97.65 P/Share
|
|
Mar 20
2020
|
Winder Investment Pte LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
86,313
+0.05%
|
$8,976,552
$104.8 P/Share
|